Featured · Hospitals & Providers
Taxpayers Protection Alliance Executive Director Ross Marchand Discusses the Flaws of the 340B Drug Pricing Program
In the latest episode of the Health Policy Podcast, Ross Marchand, Executive Director of the Taxpayers Protection Alliance, discusses the flaws of the 340B Drug Pricing Program. He highlights how the program, intended to provide discounted drugs to hospitals, has led to increased costs for taxpayers and patients as hospitals often do not pass on savings. Marchand advocates for reducing government involvement in healthcare to improve cost and quality.
2026-01-21 · with Ross Marchand
